Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Daniel Suppiger
Introduction
Daniel Suppiger is a notable inventor based in Rotkreuz, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the development of injectable implant formulations. With a total of three patents to his name, Suppiger's work is at the forefront of innovative medical solutions.
Latest Patents
Among his latest patents, Suppiger has developed a dried implant composition and an injectable aqueous implant formulation. The dried implant composition is designed for preparing an injectable formulation that can be extruded through a tapering system and a gauge 18 cannula. This composition includes a mixture of nanocrystalline hydroxyapatite particles derived from natural bone, which have a size range of 50 to 200 micrometers, and fragments of naturally crosslinked fibrous collagen material that can pass through a 0.5 mm sieve. Additionally, he has created an injectable aqueous implant formulation containing ascorbic acid, which has been sterilized by gamma-ray or X-ray irradiation. This formulation can also be extruded through a tapering system and an 18 gauge cannula, comprising a specific ratio of nanocrystalline hydroxyapatite to collagen.
Career Highlights
Suppiger's career is marked by his dedication to advancing medical technology. His work at Geistlich Pharma AG has allowed him to focus on innovative solutions that enhance patient care. His patents reflect a commitment to improving the efficacy and safety of injectable implants.
Collaborations
Throughout his career, Suppiger has collaborated with esteemed colleagues such as Paul Buxton and Nino Kurz. These partnerships have contributed to the successful development of his innovative products.
Conclusion
Daniel Suppiger's contributions to the field of biomedical engineering are significant and impactful. His innovative patents and collaborations demonstrate his commitment to advancing medical technology for better patient outcomes.